Nanjing Vazyme Biotech Co., Ltd.

SSE:688105.SS

22.38 (CNY) • At close June 16, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q2
Assets:
Current Assets:
Cash & Cash Equivalents 475.665434.24575.427541.9221,364.6721,966.891,894.7641,967.1861,603.8781,544.601953.491891.009845.1991,477.78182.637500.117-1,017.253221.602514.752
Short Term Investments 2,430.3342,221.9972,399.5512,038.2431,679.4451,513.9971,550.5891,548.0082,195.8131,719.2531,847.2941,986.1912,323.811,975.829891.399653.6912,034.506795.651241.859
Cash and Short Term Investments 2,905.9992,656.2422,474.9792,580.1653,044.1173,480.8873,445.3533,515.1943,799.6913,263.8532,800.7852,877.23,169.0093,453.6091,074.0361,153.8081,017.2531,017.253756.611
Net Receivables 502.054503.13513.014499.052403.501351.93301.947295.388506.119839.625645.517492.946509.437322.32381.833218.4470226.236230.647
Inventory 374.285362.178375.571361.266361.452346.248415.75418.717394.06364.2672.015692.527417.055242.189277.838250.6520132.37131.785
Other Current Assets 80.59849.92162.57965.68456.048050.6366.773111.1897.432165.054132.302324.96632.77145.6070019.838234.298
Total Current Assets 3,862.9353,571.4713,426.1423,486.8393,865.1184,230.2584,213.6814,296.0734,811.054,565.1094,283.374,194.9754,435.2124,050.8881,779.3141,664.9171,017.2531,395.6971,122.694
Non-Current Assets:
Property, Plant & Equipment, Net 672.632726.066736.33777.322769.421835.551736.931735.241708.399679.478892.327807.302397.088308.985275.814239.5470128.49678.989
Goodwill 130.491130.491130.491130.491130.491130.491130.491130.491130.491130.491130.61900000000
Intangible Assets 88.31295.18795.02697.1598.446101.24198.36198.56549.88249.69838.33218.62916.816.6514.79712.99507.4222.98
Goodwill and Intangible Assets 218.803225.678225.517227.641228.937231.732228.851229.055180.373180.189168.95118.62916.816.6514.79712.99507.4222.98
Long Term Investments 64.875-2,167.163-2,347.25452.33252.11447.298-1,503.32-1,525.694-2,173.499-1,696.938-1,837.451-1,969.51-2,305.998-1,957.347-872.121-633.956062.71734.645
Tax Assets 154.513146.037127.047116.651113.755106.51597.82689.8476.0567.12126.58820.5924.24924.8724.74414.05109.0888.526
Other Non-Current Assets 292.5462,546.5742,729.697319.105384.041294.8191,938.171,931.4232,716.0142,210.2532,351.3312,397.0292,891.6192,163.0741,066.956837.632,063.998.2167.986
Total Non-Current Assets 1,403.371,477.1921,471.3361,493.0521,548.2691,515.9151,498.4591,459.8651,507.3361,440.1021,601.7461,274.0411,023.758556.232510.189470.2682,063.99215.939133.125
Total Assets 5,266.3055,048.6634,897.4784,979.8915,413.3865,746.1735,712.145,755.9376,318.3866,005.2125,885.1175,469.0165,458.974,607.122,289.5032,135.1842,063.991,611.6361,255.818
Liabilities & Equity:
Current Liabilities:
Account Payables 78.5690.40383.307104.735122.229146.816163.067176.135243.769318.783369.529335.342390.962118.75693.893101.986058.58160.127
Short Term Debt 941.359551.317456.776472.339884.6691,180.1261,167.8441,154.8881,009272.209200040.01931.24824.9426.47601.15143.105
Tax Payables 015.29712.2130.1868.0320.03414.67511.9419.35982.76229.72458.514109.91737.78141.74747.915045.63659.337
Deferred Revenue 51.8450044.69343.87455.915137.208156.451133.702214.55107.73800236.329175.746168.0160178.697163.912
Other Current Liabilities 87.822246.314178.92186.095122.05136.611140.53139.036143.311265.765293.317282.77227.456104.443-41.03937.7980-34.936106.063
Total Current Liabilities 1,159.585903.332731.216763.3551,180.8531,519.5041,529.3541,549.2731,539.1411,154.069892.57676.625768.354387.262295.287297.6450239.227268.631
Non-Current Liabilities:
Long Term Debt 149.266143.364159.11172.366147.28785.50877.544107.707125.764127.68150.714127.67684.04359.93456.42863.026034.3260
Deferred Revenue Non-Current 47.99348.38449.27548.75332.79521.38318.42818.9522.3719.25322.70622.85923.51216.23618.14518.363015.35712.427
Deferred Tax Liabilities Non-Current 0.7291.2591.3221.2321.5111.5115.1692.7453.16811.18639.8891.5142.2210.8740.9820.56500.0980.279
Other Non-Current Liabilities 7.8818.71518.50517.63453.23846.2264.02760.28477.24280.91512.90915.37820.32315.52430.6445.994393.2485.72314.599
Total Non-Current Liabilities 205.869201.723228.212191.232234.831176.005165.168189.686228.544239.034226.219167.428130.192.568106.195109.586393.24840.04927.305
Total Liabilities 1,365.4541,105.054959.428954.5871,415.6841,695.5091,694.5221,738.9591,767.6851,393.1041,118.789844.053898.453479.83401.482407.231393.248279.276295.936
Equity:
Preferred Stock 0000000000000000000
Common Stock 397.735402.134400.01400.01400.01400.01400.01400.01400.01400.01400.01400.01400.01400.013603600360360
Retained Earnings 939.908937.999987.2461,024.7771,013.8341,008.6181,003.185998.4811,528.9631,579.5871,816.5361,680.7421,618.1641,186.8041,124.834966.4750574.617258.316
Accumulated Other Comprehensive Income/Loss 000278.4112,661.206246.4222,619.677223.2362,619.953222.8652,546.104137.7652,542.343134.03001,332.36100
Other Total Stockholders Equity 2,563.5622,605.1112,552.0432,555.1462,584.3062,622.479-5.7262,620.94802,629.31102,544.2102,406.446350.745401.478338.381397.743341.566
Total Shareholders Equity 3,901.2053,945.2433,939.2993,977.5113,998.1514,029.3884,017.1464,016.0754,548.9264,608.9074,762.6514,624.9634,560.5174,127.291,888.0211,727.9531,670.7421,332.361959.882
Total Equity 3,900.853,943.6093,938.053,976.5513,997.7024,029.284,017.6184,016.9784,550.7014,612.1084,766.3284,624.9634,560.5174,127.291,888.0211,727.9531,670.7421,332.361959.882
Total Liabilities & Shareholders Equity 5,266.3055,048.6634,897.4784,979.8915,413.3865,746.1735,712.145,755.9376,318.3866,005.2125,885.1175,469.0165,458.974,607.122,289.5032,135.1842,063.991,611.6361,255.818